Surgery for oligometastasis of pancreatic cancer

Fengchun Lu, Katherine E. Poruk, Matthew J Weiss

Research output: Contribution to journalArticle

Abstract

The incidence of pancreatic adenocarcinoma (PDAC) has steadily increased over the past several decades. The majority of PDAC patients will present with distant metastases, limiting surgical management in this population. Hepatectomy and pulmonary metastasectomy (PM) has been well established for colorectal cancer patients with isolated, resectable hepatic or pulmonary metastatic disease. Recent advancements in effective systemic therapy for PDAC have led to the selection of certain patients where metastectomy may be potentially indicated. However, the indication for resection of oligometastases in PDAC is not well defined. This review will discuss the current literature on the surgical management of metastatic disease for PDAC with a specific focus on surgical resection for isolated hepatic and pulmonary metastases.

Original languageEnglish (US)
Pages (from-to)358-367
Number of pages10
JournalChinese Journal of Cancer Research
Volume27
Issue number4
DOIs
StatePublished - 2015

Fingerprint

Pancreatic Neoplasms
Metastasectomy
Neoplasm Metastasis
Lung
Liver
Hepatectomy
Disease Management
Patient Selection
Lung Diseases
Colorectal Neoplasms
Adenocarcinoma
Incidence
Population
Therapeutics

Keywords

  • Hepatic metastasis
  • Oligometastasis
  • Pancreatic cancer (PC)
  • Pulmonary metastasis
  • Surgical management

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Surgery for oligometastasis of pancreatic cancer. / Lu, Fengchun; Poruk, Katherine E.; Weiss, Matthew J.

In: Chinese Journal of Cancer Research, Vol. 27, No. 4, 2015, p. 358-367.

Research output: Contribution to journalArticle

Lu, Fengchun ; Poruk, Katherine E. ; Weiss, Matthew J. / Surgery for oligometastasis of pancreatic cancer. In: Chinese Journal of Cancer Research. 2015 ; Vol. 27, No. 4. pp. 358-367.
@article{b4c5d97d64c54f029b7e17cf3416292a,
title = "Surgery for oligometastasis of pancreatic cancer",
abstract = "The incidence of pancreatic adenocarcinoma (PDAC) has steadily increased over the past several decades. The majority of PDAC patients will present with distant metastases, limiting surgical management in this population. Hepatectomy and pulmonary metastasectomy (PM) has been well established for colorectal cancer patients with isolated, resectable hepatic or pulmonary metastatic disease. Recent advancements in effective systemic therapy for PDAC have led to the selection of certain patients where metastectomy may be potentially indicated. However, the indication for resection of oligometastases in PDAC is not well defined. This review will discuss the current literature on the surgical management of metastatic disease for PDAC with a specific focus on surgical resection for isolated hepatic and pulmonary metastases.",
keywords = "Hepatic metastasis, Oligometastasis, Pancreatic cancer (PC), Pulmonary metastasis, Surgical management",
author = "Fengchun Lu and Poruk, {Katherine E.} and Weiss, {Matthew J}",
year = "2015",
doi = "10.3978/j.issn.1000-9604.2015.05.02",
language = "English (US)",
volume = "27",
pages = "358--367",
journal = "Chinese Journal of Cancer Research",
issn = "1000-9604",
publisher = "Beijing Institute for Cancer Research",
number = "4",

}

TY - JOUR

T1 - Surgery for oligometastasis of pancreatic cancer

AU - Lu, Fengchun

AU - Poruk, Katherine E.

AU - Weiss, Matthew J

PY - 2015

Y1 - 2015

N2 - The incidence of pancreatic adenocarcinoma (PDAC) has steadily increased over the past several decades. The majority of PDAC patients will present with distant metastases, limiting surgical management in this population. Hepatectomy and pulmonary metastasectomy (PM) has been well established for colorectal cancer patients with isolated, resectable hepatic or pulmonary metastatic disease. Recent advancements in effective systemic therapy for PDAC have led to the selection of certain patients where metastectomy may be potentially indicated. However, the indication for resection of oligometastases in PDAC is not well defined. This review will discuss the current literature on the surgical management of metastatic disease for PDAC with a specific focus on surgical resection for isolated hepatic and pulmonary metastases.

AB - The incidence of pancreatic adenocarcinoma (PDAC) has steadily increased over the past several decades. The majority of PDAC patients will present with distant metastases, limiting surgical management in this population. Hepatectomy and pulmonary metastasectomy (PM) has been well established for colorectal cancer patients with isolated, resectable hepatic or pulmonary metastatic disease. Recent advancements in effective systemic therapy for PDAC have led to the selection of certain patients where metastectomy may be potentially indicated. However, the indication for resection of oligometastases in PDAC is not well defined. This review will discuss the current literature on the surgical management of metastatic disease for PDAC with a specific focus on surgical resection for isolated hepatic and pulmonary metastases.

KW - Hepatic metastasis

KW - Oligometastasis

KW - Pancreatic cancer (PC)

KW - Pulmonary metastasis

KW - Surgical management

UR - http://www.scopus.com/inward/record.url?scp=84940562523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940562523&partnerID=8YFLogxK

U2 - 10.3978/j.issn.1000-9604.2015.05.02

DO - 10.3978/j.issn.1000-9604.2015.05.02

M3 - Article

C2 - 26361405

AN - SCOPUS:84940562523

VL - 27

SP - 358

EP - 367

JO - Chinese Journal of Cancer Research

JF - Chinese Journal of Cancer Research

SN - 1000-9604

IS - 4

ER -